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Chemical assembly of N-glycoproteins: a refined
toolbox to address a ubiquitous posttranslational
modification†‡
Carlo Unverzagt*a and Yasuhiro Kajihara*b
Incremental developments in the chemistry of peptides, proteins and carbohydrates have enabled
researchers to assemble entire glycoproteins with high precision. Based on sophisticated ligation
chemistries pure glycoproteins bearing a single glycosylation pattern have become available. The impact
of N-glycosylation on the function of glycoproteins is generally recognized but not well understood.
Based on the recent advances in the synthesis of glycoproteins by chemical methods researchers can
finally start to elucidate the various roles of carbohydrates in complex biomolecules in detail.
1. Introduction
The many functions of proteins associated with their complex
three-dimensional architectures are fascinating to scientists
from many fields. Additional functionality of proteins is pro-
vided by their covalent modification with sugars, lipids, phos-
phates and other residues summarized as posttranslational
modifications (PTMs). Phosphorylation is frequently involved
in signal transduction, ubiquitination regulates proteolysis,
and the attachment of lipids results in membrane anchoring.
Depending on the type of PTM, the physical and chemical
properties of a protein including folding, conformational
properties and stability are altered resulting in a modified
functionality of the protein.1 Thus PTMs have received con-
siderable attention. Glycosylation is a frequently encountered
posttranslational modification based on a complex biosynthetic
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machinery affecting protein function in many ways.2 Nearly all
the secretory proteins found on cell surfaces and in body fluids
are glycoproteins. Thus more than 50% of all human proteins
are expected to be glycosylated.3 Glycoproteins play important
roles in many biological events4 such as cell–cell recognition,
immune response and development. A general goal of PTM-
related research is to understand how these modifications
effectively regulate protein functions.
In order to reveal the functions of carbohydrates attached to
proteins, biological experiments rely on glycoproteins prepared
by recombinant expression. Due to their biosynthesis natural
glycoproteins exhibit considerable heterogeneity in their oligo-
saccharide structures.5 Unfortunately, the microheterogeneity
of glycoproteins cannot be resolved routinely by chromato-
graphic methods.6 Thus the attempts to determine the bio-
logical role of a particular oligosaccharide in the protein of
interest are frequently based on mixtures of glycoforms.
In order to resolve these questions, the availability of homo-
geneous glycoproteins is essential. Until recently, glycoproteins
could only be obtained by biological means7 since chemical
methods were not available for the preparation of these
complex biomacromolecules.
This review describes the recent chemical approaches resulting
in the preparation of homogeneous glycoproteins bearing
complex asparagine linked (N-linked) oligosaccharides.
2. Biosynthesis of glycoproteins
The glycosylation of proteins is found in all classes of organ-
isms and displays a variety of related carbohydrate structures.2
All the enzymes involved in glycoprotein biosynthesis are
potentially useful for recombinant production7 as well as
enzymatic synthesis of glycoproteins. In mammalian cells
cytosolic glycoproteins bear only a short O-linked modifi-
cation (O-GlcNAc) attached to Ser/Thr moieties.8 The main
source of glycoproteins is linked to the secretory pathway
originating in the endoplasmic reticulum (ER). There a complex
biosynthetic pathway occurs in a co- and/or posttranslational
manner.
According to the mode of attachment the sugar part of
secretory glycoproteins can be classified as an O-linked or
N-linked type.2 In the O-linked type, an N-acetyl-a-D-galactos-
amine (GalNAc) residue is connected to the OH of serine or
threonine. The transfer of additional sugars in the Golgi-
apparatus gives rise to eight basic core structures of moderate
complexity. For the N-linked type, a unique 14-mer oligo-
saccharide is transferred en bloc to the amide nitrogen of an
asparagine of the Asn-X-Ser/Thr recognition sequence. The
14-mer on the nascent glycoprotein is subjected to enzymatic
degradation and remodelling in the ER and the Golgi appa-
ratus. Subsequently, the final N-glycoprotein is translocated to
the cell surface or secreted (Fig. 1).
The resulting N-glycans can be distinguished by their
terminal carbohydrate composition into three types: complex,
hybrid, and high-mannose structures (Fig. 2). The highest
diversity is found in the complex structures where multiple
branching is accompanied by terminal capping with sialic acid
containing motifs and distinct modifications of the core
pentasaccharide. High-mannose N-glycans from higher eukaryotes
are weakly processed structures bearing only terminal mannose
residues derived from the nascent 14-mer. In hybrid N-glycans
complex-type termini are present in the 1,3-branch combined
with a high-mannose part in the 1,6-branch.
The biosynthesis of N-glycoproteins has been studied exten-
sively. A dolichol phosphate embedded in the lipid bilayer of
the endoplasmic reticulum (ER) is enzymatically elongated with
GlcNAc, Man and Glc residues. The 14-mer oligosaccharide of
Fig. 1 Key steps in the biosynthesis of N-glycoproteins (OST = oligosaccharyl-
transferase).
Fig. 2 Main types of N-glycans found on N-glycoproteins.
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the Glc3Man9GlcNAc2 (G3M9) diphospho-lipid can be trans-
ferred to the nascent peptide chain entering the ER following
an intriguing mechanism.9 The glycosylated polypeptide is
further elongated and subsequent folding yields a native glyco-
protein. This folding process is either spontaneous or can be
supervised by several enzymes and chaperones, which rigorously
discriminate misfolded and correctly folded glycoproteins. The
carbohydrate-guided refolding machinery is referred to as the ER
glycoprotein quality control system.10
Properly folded glycoproteins are transported into the Golgi
apparatus, whereas misfolded glycoproteins are translocated to
the cytoplasm for degradation. In the Golgi apparatus, several
glycosidases and glycosyltransferases convert the initial
high-mannose type oligosaccharides into complex-type oligo-
saccharides or hybrid-type oligosaccharides. During this
process, a considerable variety of the final oligosaccharides
is generated. The resulting mixture of glycoforms makes it
difficult to elucidate to what extent individual N-glycans are
involved in trafficking, secretion and bioactivity of each glyco-
form. Structure–activity relationships have been established
e.g. for sialylated N-glycans on circulatory glycoproteins11,12 as
well as for core-fucosylated N-glycans on immunoglobulins
(ADCC).13 An immunosuppressive component of IgG was found
to be dependent on a unique sialylated N-glycan.14 N-Glycans
can directly affect the stability of the glycoprotein by intra-
molecular interaction.15
3. General synthetic considerations for
N-glycoproteins
Many approaches for the synthesis of glycoproteins and their
analogues16–23 have been established, however, only in a few
cases homogeneous glycoproteins were obtained. Retrosynthetic
analysis gives a multitude of possible disconnections, but not
all of them have a synthetic equivalent (Fig. 3). A possibility for
attaching N-glycans to non-glycosylated proteins would be most
desirable. Hitherto no chemical or enzymatic options have
been found to be applicable for this task. A convenient
alternative is a disconnection within the chitobiose part of
the N-glycan to a simple GlcNAc glycoprotein and a truncated
N-glycan. The endoglycosidases catalyzing this cleavage reac-
tion are involved in the breakdown of glycoproteins. It is
known, however, that these endoglycosidases can also be used
for synthesis,24 since they catalyze the reverse reaction at
preparatively useful rates, whenever the transferred sugar is
activated as an oxazoline.25
The highest degree of flexibility is currently available by
assembling the glycoprotein from shorter peptides. The most
powerful method is native chemical ligation,26 which takes
advantage of the high reactivity of N-terminal cysteines in
unprotected peptides with peptide thioesters (Fig. 4). Native
chemical ligation has enabled the synthesis of many full-length
proteins including modified proteins.27 The required peptide
fragments (thioesters or Cys-peptides) can be obtained by chemical
or enzymatic synthesis as well as by recombinant expression.28
Based on this elaborated approach the incorporation of glyco-
peptides should lead to glycoproteins. Recombinant protein
fragments for native chemical ligation are not limited by
length restrictions, whereas peptides obtained by solid phase
synthesis are limited to 40–50-mers for technical reasons.
Fig. 3 Useful retrosynthetic pathways for the strategic disconnection of
N-glycoproteins.
Fig. 4 Fragment coupling of unprotected peptides by native chemical ligation
(NCL).
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Usually synthetic glycopeptides bearing biorelevant N-glycans
are quite difficult to obtain in a similar length. Therefore,
multiple ligations may be necessary, depending on the posi-
tion of the oligosaccharides and the length of the available
fragments.
Generally, the low overall abundance of cysteine residues in
proteins (1–2%) may require alternative or additional ligation
sites. Two solutions of this problem have emerged: the use of
temporary auxiliaries29 and the selective desulfurization of thiol
groups.30–32 Whereas the cysteine-mimicking auxiliaries have
shown limited applicability and may result in low efficiency
ligations, the selective desulfurization of cysteine and a number
of other thiol-containing amino acids has found wide accep-
tance among ligation chemists (Fig. 5).
Regardless of the availability of a fairly elaborated spectrum of
useful ligation sites, the synthesis of the required glycopeptides33,34
still remains challenging. This is mainly caused by the limited
availability of N-glycans in larger amounts, followed by carbo-
hydrate related side reactions during glycopeptide synthesis.
Synthetic N-glycans of nearly any desired structure are available
for specialized labs only and multistep syntheses curb the
final amounts of these oligosaccharides. Sufficient amounts
of biantennary N-glycan model compounds can be obtained by
isolation of a sialoglycopeptide from egg yolk.20 For the syn-
thesis of N-glycopeptides two main strategies exist, namely the
cassette approach, wherein preformed glycosylamino acids are
employed in stepwise elongations, or the convergent method,35
where the peptide is synthesized first and subsequently the
N-glycan is coupled to the peptide chain (Lansbury aspartylation).
Sequential ligations are mainly carried out using peptide
thioesters, wherein a temporary protecting group masks an
N-terminal cysteine residue.36 After the first ligation the N-terminal
cysteine is liberated and selectively ligated with another thioester
fragment (Fig. 6). A less general alternative is provided by
kinetically controlled ligations.37 In this case a more reactive
aromatic peptide thioester is ligated with a Cys-peptide bearing
a less reactive aliphatic thioester, thereby allowing the exten-
sion of the peptide by ligation in the C-terminal direction. An
improved modification of this concept takes advantage of
latent thioesters38 (thioester precursors), which permit a free
choice of the direction of sequential ligations (Fig. 7).
4. Synthesis of glycoprotein fragments
The availability of protein fragments for the native chemical
ligation of proteins has improved substantially in the nearly
two decades since the seminal publication26 in 1994. At first
only chemical synthesis could provide peptides with a thioester
functionality. However, the use of inteins has revealed a viable
path for recombinant thioesters of virtually any length.28,39 The
chemical synthesis of peptide thioesters follows two principles:
either the thioester is generated on the resin or a peptide acid is
cleaved off the resin and subsequently converted to a thioester.
Thioesters are accessible via Fmoc-40 and Boc-strategies.41 The
presence of a thioester functionality is known to facilitate
epimerization of the C-terminal amino acid even under weakly
basic ligation conditions.42 This stimulated the recent develop-
ment of several latent thioester concepts,38 where thioester
precursors remain stable during peptide synthesis and global
deprotection. Under special conditions, also including ligation
conditions, the thioester can be generated from the stable
precursors.
Peptide thioesters, which are not accessible by solid phase
methods (above 50–100 amino acids), can be obtained routinely
Fig. 5 Selective removal of thiol groups after native chemical ligation converts
cysteine to alanine with high efficiency.
Fig. 6 Sequential native chemical ligations with N-terminal cysteine masked as
a thiazolidine.
Fig. 7 Latent thioesters in combination with orthogonally protected N-terminal
cysteines allow selective peptide elongations in N- and C-terminal directions.
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by recombinant expression of the peptide C-terminally fused to
an intein (Fig. 8).39 Inteins are self-cleaving proteases involving
internal thioester intermediates. By intercepting these thioester
intermediates with external thiols, the thioester is liberated
from the intein and can be isolated. It is recommended to
choose the intein according to the C-terminal amino acid, since
most inteins show preferences for certain amino acids at the
cleavage site. However, this method usually retains a methionine
at the N-terminus of the peptide thioester.
In order to recombinantly generate peptides (including their
thioesters) with an N-terminal cysteine or any other native
N-terminal amino acid special approaches are needed. Estab-
lished methods include the use of specific proteases e.g. SUMO-
protease,43 factor Xa,44 TEV protease45 or self-cleaving inteins39
in some cases.
The linear chemical synthesis of glycopeptides and their thio-
esters is mainly performed on the solid phase. In this approach, an
asparagine linked N-glycan is employed for peptide elongation.
Due to the lability of oligosaccharides to strong acids this approach
usually follows the Fmoc strategy. However, the acid lability of the
O-glycosidic linkages of N-glycans can be overcome by esterifi-
cation of free hydroxyl groups46 and carboxylates,47 enabling also
Boc-based glycopeptide synthesis, which will be discussed later.
When the N-glycan-Asn building block is readily available
the Fmoc-based cassette approach can be applied. After choosing
an appropriate resin–linker combination the elongation is
carried out. In our hands the use of more hydrophilic resins
is crucial, when larger N-glycans of about 10 residues are to
be incorporated into the peptide chain. Typically PEGA48 or
ChemMatrix resins are preferred over polystyrene-based sup-
ports. A multitude of robust linkers is compatible with glyco-
peptide synthesis leaving the choice to the chemist whether the
thioester should be generated on the resin or after cleavage of
the glycopeptide (Fig. 9).
Post-cleavage thioesterification of protected glycopeptide
acids can be troublesome whenever the cleaved peptide is not
well soluble or aggregates. Depending on the sequence the final
glycopeptide may also be retained on the resin.49 However, for
shorter and well soluble glycopeptides the post-cleavage thio-
esterification appears to be more efficient.50
The elongation of the solid phase-bound peptide with the
sugar–Asn conjugate is typically carried out using a low excess
of the precious building block. When incorporating GlcNAc-Asn
the sugar hydroxyls can be protected by acetylation. However,
larger N-glycans with acetyl protection51 were found to block
extension of the peptide chain beyond 20 amino acids.52 The
example in Fig. 10 shows the use of temporary acetyl protection
on a biantennary nonasaccharide N-glycan, which was compa-
tible with the elongation to the 14mer glycopeptide thioester 2.
The acetates were removed on the resin by hydrazinolysis prior
to establishing the thioester functionality.52 As a consequence
the hydroxyl groups of N-glycan-Asn building blocks (e.g. 1 and 3)
were kept unprotected after incorporation into the peptide,
which improved the following peptide elongation. However,
care must be taken in order to avoid esterification of the
hydroxyl groups during chain extension and capping pro-
cedures. It was found that maintaining the concentration of
activated amino acids below 40 mMmay reduce esterification of
Fig. 8 Recombinant methods for the generation of (a) thioesters and
(b) Cys-peptides.
Fig. 9 Linker systems compatible with the synthesis of complex glycopeptide
thioesters.
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the sugar to a very low level.53 Alternatively, on-resin hydrazi-
nolysis can remove undesired esterification, whenever the
linker is not susceptible to these conditions.52 Hydrazinolysis
is not compatible with sialic acid moieties protected by ester
groups and some types of linkers. Sialylated N-glycan-Asn
derivatives can be incorporated into Fmoc-SPPS as a benzyl
protected ester (3, Fig. 11).47,54 The esters can be cleaved under
basic conditions after completion of the peptide synthesis.
Boc-based glycopeptide synthesis can be carried out using
N-glycan-Asn derivatives with protected sialic acid.55 When stronger
acids are needed for side chain deprotection a more stable
protecting group for the sialic acid carboxylate is required.
This requirement was met with phenacyl esters.56 In Fig. 12
the synthesis of glycosylated EPO 79–97 thioester 6 is shown.
Strong acid was applied to the resin-bound glycopeptide thio-
ester followed by transthioesterification using thiol (MESNa)
in 6 M GdnCl. In general the incorporation of sialic acid
into glycopeptides adds more complexity and requires a case-
by-case evaluation. A less demanding approach started with
the synthesis of a glycopeptide bearing a synthetic N-glycan
followed by enzymatic galactosylation and sialylation at a later
stage.57
By following the stepwise approach (elongation by single
amino acids) glycopeptides and the corresponding thioesters of
about 20 amino acids bearing full length N-glycans were
obtained. This barrier was overcome by convergent elongation
of the peptide chain on the resin with longer peptide frag-
ments. Thus side reactions on the sugar hydroxyls could be
reduced and reverted by on-resin hydrazinolysis. However,
C-terminal epimerization during fragment condensation poses
a more serious problem. If C-terminal glycines or prolines are
not available, a racemization-free glycopeptide elongation can be
carried out using fragments with a C-terminal pseudoproline.
This method led to the 1–39 RNase thioester 7 (Fig. 13).58
Compared to peptides the sequential elongation of glyco-
peptides is more demanding and can lead to unsatisfactory
results in particular when difficult or longer sequences are
targeted. Under these circumstances an alternative approach
can be helpful, wherein the carbohydrate is attached to the
peptide chain as the last step. This convergent approach is
known as the Lansbury aspartylation35 and can be carried out
with peptides obtained by automatic peptide synthesis. The
Lansbury aspartylation was developed as a solution phase
method, but can also be carried out on the solid phase.
Complex glycopeptide thioesters were synthesized by this
Fig. 10 Synthesis of the RNase 26–39 glycopeptide thioester 2 using temporary
acetyl protection on the oligosaccharide.
Fig. 11 Synthesis of IFN beta glycopeptide thioester 4 bearing benzyl protected
sialic acids.
Fig. 12 Synthesis of a glycopeptide thioester by use of Boc SPPS with sialic acids
protected by phenacyl esters (Pac).
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method mainly by the Danishefsky group.19 Despite many
advantages the aspartylation approach also suffers from a few
drawbacks. The aspartate to be coupled with a glycosyl amine
requires an additional orthogonal protecting group and is
prone to aspartimide formation throughout the synthesis. Only
recently this drawback could be reduced efficiently by use of
pseudoprolines at the Ser/Thr residues of the consensus
Asp-X-Ser/Thr sequence. Using this approach in solution59 or
on the solid phase49 long glycopeptide thioesters of high com-
plexity have become available (Fig. 14). This approach should
further pave the way for the extension of the chemical synthesis
of glycoproteins, as shown in a recent example of a synthetic EPO
where all four glycosylation sites were occupied.60
At this point the availability of N-glycan-Asn derivatives as
well as N-glycans needs to be addressed. For biantennary
N-glycans a convenient source for a short sialoglycopeptide
(SGP) from egg yolk61 was exploited. Kajihara et al. showed
that it is possible to degrade the disialylated undecasaccharide
to numerous valuable Fmoc-Asn building blocks (e.g. 1),62
which allows us to obtain the desired compounds routinely in
amounts of several hundred milligrams (Fig. 15).
Chemical synthesis of N-glycans is carried out at a high level
in several specialized laboratories and mainly follows a con-
vergent strategy based on derivatives of the core trisaccharide.
The core trisaccharide bears a b-mannoside as the most chal-
lenging linkage. Selective elongation of this core scaffold allows
the attachment of antennae as well as typical core modifica-
tions, e.g. core fucose or bisecting GlcNAc. Fig. 16 shows a
synthetic dodecasaccharide (15) representing the highest
density of branches in complex-type N-glycans.63 By use of less
branched building blocks virtually all the desired cores of
complex-type N-glycans can be accessed.
Fig. 13 Racemization-free elongation of glycopeptides by fragments containing
C-terminal pseudoproline.
Fig. 14 Convergent synthesis of glycopeptide thioesters assisted by consensus
Ser/Thr pseudoproline: (a) on the solid phase; (b) in solution.
Fig. 15 Isolation of biantennary N-glycan-Asn building blocks from egg yolk.
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Even N-glycans with completely sialylated termini can be
established chemically, however, enzymatic methods can pro-
vide a more rapid and easily variable access to biorelevant
structures.57 Depending on the synthetic strategy an anomeric
azide may be incorporated early in the synthesis63 or attached
as a final step (Fig. 17a).64 The glycosyl amine needed for
coupling to the peptide can be obtained by reduction of an
azide or via Kochetkov amination.65 Care should be taken since
a side reaction of the amination can cause loss of the reducing
end GlcNAcmoiety.66 Oxazolines of truncated N-glycans required
for transglycosylation were initially synthesized only chemically
but recently convenient methods emerged for the semisynthetic
conversion of truncated N-glycans to oxazolines even in aqueous
solvents (Fig. 17b).67
Ligation methods
Native chemical ligation of peptides can be carried out in the
presence of a multitude of buffers, solvents and additives
ranging from plain water to 6 M guanidinium chloride or 8 M
urea containing organic solvents, detergents, thiols and redu-
cing agents (Fig. 4). The first step (transthioesterification) is
reversible whereas the second step (S- N acyl transfer) traps
the desired native amide product. The free side chains of the
peptide usually do not interfere and thioester formation on
interior thiols is reversible and non-productive. Once the frag-
ments needed for glycoprotein assembly are available, their
ligation can be investigated. It is recommended to test the
efficiency of the ligation sites early on using small model
peptides.68 The typically employed alkyl thioesters are only
moderately activated, but after addition of 50–200 mM MPAA
(or other thiophenols) transthioesterification to a reactive
phenolic thioester occurs.69
In case the glycoprotein contains cysteines at appropriate
positions, the length of the fragments can be adjusted according
to the synthetic availability and the minimal number of liga-
tions. For proteins without cysteines at strategically useful
positions (about 40 amino acids maximum for fragments) other
ligation sites are required. One option is the use of temporary
auxiliaries.29 However, the use of thiolated amino acids followed
by desulfurization bears more advantages and has recently
become the method of choice for ligations without a native
Cys. Desulfurization can be carried out efficiently and selec-
tively by a radical process under homogeneous conditions31
and was shown for a third of the natural amino acids (Ala, Val,
Leu, Pro, Thr, Phe, Lys, Gln) (Fig. 18). Radical desulfurization is
compatible with thioether functionalities (methionine, Acm
protected cysteine and thiazolidine). A special ligation method
Fig. 16 Key building blocks for modular synthesis of multiantennary N-glycans
bearing bisecting GlcNAc and core fucose.
Fig. 17 (a) Semisynthetic approaches to N-glycan azide 17 and the corre-
sponding amine 8; (b) complex-type oxazoline 18.
Fig. 18 Various thiolated amino acids are compatible with NCL and can be
converted to sulfur-free amino acids within the ligation product.
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requiring no thiol groups is the direct aminolysis of peptide
thioesters using partially protected peptides.70
Once the ligation sites are defined the ligations need to be
arranged in a sequence depending on the features of the
fragments. Sequential ligations (more than two fragments)
are usually carried out from the C-terminus to the N-terminus.
The cysteines of the inner fragments carry a temporary protec-
tion e.g. as thiazolidine,36 which needs to be removed prior to
the following ligation. This directional limitation can be over-
come by applying kinetically controlled ligations.37 Herein a
more reactive (aromatic) thioester is C-terminally elongated by
a less reactive thioester, which needs to remain stable under
the ligation conditions.
A safer way to carry out multiple C-terminal extensions is to
employ latent thioesters (Fig. 19). Several variants of latent
thioesters were developed recently,42,71–75 which led to a gen-
erally increased flexibility in the sequence of ligations. By
means of latent thioesters the instability and base sensitivity
of the thioester functionality can be circumvented elegantly.
This robustness gives new options during assembly of the
fragments and for establishing a desired order of the ligations.
Whenever the size of the fragments varies considerably purifi-
cation issues may arise, which can be resolved by alternative
ligation sequences. Additionally, selective desulfurization steps
can be integrated with greater ease.
5. Synthesis of N-glycoproteins
The following examples are organized in a timely sequence,
which underlines the rapid incorporation of synthetic advances
and the increasing complexity of the target glycoproteins. A key
example reported by the Wang group, in which chemoenzymatic
N-glycoprotein remodeling was carried out efficiently on
RNase B, has led to an RNase B glycoform with a natural
N-glycan structure. Isolated RNase B is a mixture of at least
five natural glycoforms (Man5–9GlcNAc2), which can be degraded
enzymatically to a single GlcNAc-RNase by use of Endo-A.
The truncated glycoprotein (GlcNAc-RNase) can be purified by
HPLC and extended enzymatically, e.g. with the tetrasaccharide
oxazoline 19, to yield a homogeneous glycoform of RNase B
bearing the core pentasaccharide (Fig. 20).76 This approach was
extended and further elaborated also by Fairbanks et al.77
employing Endo-glycosynthases capable of transferring more
complex oxazolines without hydrolyzing the final glycoprotein
products.22
The first synthesis of homogenous glycoprotein bearing a
fully synthetic peptide backbone and a semisynthetic sialylated
N-glycan55 was carried out in a joint project of the Kajihara and
the Dawson group. The cytokine MCP-3 has 76 amino acids,
two disulfides and an N-terminal N-glycosylation site, which
allowed assembly by two sequential ligations using a short
glycopeptide thioester and two longer peptide segments
(Fig. 21). The sialylated glycopeptide thioester was accessible
by Fmoc methodology, but additionally a novel Boc based
approach with no protection on the side chains could be
established. The minimal protection approach effectively
circumvented the use of HF, which is not compatible with the
oligosaccharide. Ligation of the three segments proceeded
smoothly, and after oxidative refolding the benzyl protection
of the terminal sialic acid residues was removed as the final
step. The native state of the synthetic glycoprotein cytokine
MCP-3 was confirmed by CD-spectroscopy, ELISA as well as
disulfide mapping.
One year later the first semisynthesis of a glycoprotein
with enzymatic activity was completed by the Unverzagt
group.52,78 RNase C is a glycoform of bovine RNase bearing a
Fig. 19 Examples for latent thioesters and their activation conditions.
Fig. 20 Synthesis of a homogeneous glycoform of RNase B by enzymatic
remodeling using the endoglycosidase Endo-A.
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complex type N-glycan. The glycoprotein encompasses 124 amino
acids and eight cysteines engaged in four disulfide bridges.
A three segment strategy was chosen since the 1–39 glycopeptide
thioester58 was not accessible by conventional methods at the
time. Another key fragment was the 40–124 peptide, which was
obtained recombinantly using intein cleavage and in situ protec-
tion as mixed disulfides (Fig. 22). This type of protection facili-
tated the isolation as well as the following expressed protein
ligation. The full length peptide was refolded from the second
ligation mixture, purified and characterized by CD-spectroscopy
and enzymatic activity.
Among many examples from the Danishefsky lab the syn-
theses of the alpha and beta subunit of the follicle stimulating
hormone FSH bearing two sialylated and core fucosylated
N-glycans are particularly noteworthy (Fig. 23).79,80 The alpha
subunit (92 aa) serves as a universal subunit for the four human
glycoprotein hormones and displays two N-glycans and ten
cysteine moieties. Fmoc synthesis of the required glycopeptide
thioesters was unexpectedly demanding and led to an opti-
mized ligation scheme. The convergent synthesis of the glyco-
peptide fragments was based on acid labile protection of the
aspartate side chain and optional allyl type side chain protec-
tion for other acidic or basic side chains. After optimizing the
scheme for chitobiose the valuable synthetic dodecasaccharide
N-glycan (71 steps) was incorporated substoichometrically in
good yields. Further difficulties arose in the deallylation step
and a guanidinium adduct formation on a histidine. However,
the three sequential ligations proceeded without affecting
the two sensitive N-glycans. In a similar fashion the b-subunit
could be assembled successfully. Both subunits were kept with
an Acm protection on most of the cysteines and should be
amenable to refolding of the entire hormone after deprotection.
Synthetic glycopeptide chemistry also permits the genera-
tion of designed model glycoproteins not available in biological
systems. In this example from the Kajihara lab an IL-8, which is
not glycosylated in nature, was equipped with a Man9GlcNAc2
N-glycan (Fig. 24). This glycan can be glucosylated by enzymes
of the glycoprotein quality control in the ER and was intended
to serve as a probe for misfolded protein folds.81 The oligo-
mannosidic N-glycan-Asn building block was isolated from egg
yolk as a side product and incorporated by Fmoc chemistry
close to the N-terminus of the 39mer fragment. Ligation gave
the full length IL-8, which was subjected to oxidative refolding
conditions with and without disulfide shuffle. Refolding in the
presence of a shuffle gave a high yield of glycoprotein with
Fig. 21 Synthesis of sialylated MCP-3 by sequential NCL.
Fig. 22 Synthesis of RNase C by sequential NCL.
Fig. 23 Synthesis of the alpha and beta subunit of human FSH.
Fig. 24 Synthesis of an N-glycosylated IL-8 model glycoprotein used in folding
studies.
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the native fold, whereas in the absence of a shuffle three
additional misfolded entities could be detected and separated
by HPLC. The foldamers were characterized by disulfidemapping,
CD spectroscopy, ANS binding and a functional assay using the
ER glucosyltransferase UGGT.
The glycosylated interferon-b-1a is a powerful cytokine,
which is approved as a drug against multiple sclerosis. IFN-
b-1a comprises 166 amino acids, one N-glycosylation site in the
central part and three cysteines at strategically less suitable
positions. Thus a three segment sequential ligation strategy
was devised based on artificially introduced cysteines for con-
venient ligation and subsequent desulfurization to the native
alanine residues (Fig. 25).54 The sialic acid moieties of the
central glycopeptide thioester were protected as benzyl esters.
Each ligation step was followed by a mild desulfurization and
finally yielded the full length glycoprotein chain. After removal
of the Acm groups and the benzylesters the glycoprotein was
folded to the native state. The synthetic IFN-b-1a was charac-
terized by disulfide mapping, CD spectroscopy and comparative
in vitro and in vivo bioactivity studies revealing striking simi-
larity to commercial products.
An example for glycoprotein synthesis, wherein radical
desulfurization was employed extensively, is the synthesis of
an erythropoietin (EPO) with a sialylated N-glycan at Asn 83
(Fig. 26).56 Due to its unique biological activity EPO is one of the
best studied therapeutic glycoproteins. The four cysteines of
the 166 aa EPO are located close to the termini warranting
alternative ligation sites. Thus the four native cysteines were
kept protected by Acm throughout, and five alanines were
selected as ligation sites for the six fragments. For the central
glycopeptide thioester novel conditions based on Boc chemistry
were established. In order to incorporate a sialylated N-glycan,
the carboxylic acid of the sialoside must be esterified. Since the
established benzyl ester was not stable during strong acid
treatment, the more robust phenacyl ester was employed. This
protection allowed the generation of the glycopeptide thioester
using a thiol linker. After global side chain deprotection the Pac
protected sialoglycopeptide thioester was released from the
resin by thiolysis (Fig. 11). Four fragments were ligated sequen-
tially from the C-terminus. Prior to the third ligation the Pac
group (in conjunction with Trp-formyl) was conveniently
cleaved by piperidine. The glycopeptide 50–166 was subjected
to desulfurization of the three free thiol groups. A final ligation
gave the full-length polypeptide, which was dethiolated prior to
Acm deprotection of the four native cysteines. Oxidative refolding
gave an EPO with three mutations and a sialylated N-glycan at
Asn 83. CD spectroscopy suggests correct folding. The compound
is designed to probe if in vivo bioactivity of EPO can be attained
by a single N-glycan.
The synthesis of a member of very hydrophobic family of
glycoprotein was reported by Hojo et al.82 (Fig. 27). Despite a
length of 80 amino acids only two of the six cysteines of saposin
C are useful for ligations. Unfortunately the N-terminal 1–34
thioester was poorly soluble and led to serious difficulties in
synthesis and ligation. Both difficulties could be improved by
Fig. 25 Synthesis of sialylated human interferon beta (IFN beta).
Fig. 26 Multi-segment ligations at non-native cysteines giving a mutant EPO
with a sialylated N-glycan at Asn 83 after desulfurization.
Fig. 27 Synthesis of saposin C using an O-acylisopeptide thioester and enzy-
matic transglycosylation by an Endo-M glycosynthase.
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incorporating an O-acylisopeptide bond, which facilitated the
synthesis of the GlcNAc containing segment 1–34. The thioester
was generated from a latent N-ethyl-Cys precursor. Both seg-
ments were colyophilized prior to ligation, thus ensuring
proper solubility in the denaturant. After removal of the Acm
groups the GlcNAc saposin C was refolded in the presence of
DMSO and purified. Enzymatic transfer of a complex-type
N-glycan was accomplished using the fully synthetic octa-
saccharide oxazoline 18 and a glycosynthase derived from
Endo-M. The reaction required DMSO as a cosolvent. The bio-
logical activity of the differently glycosylated saposin C forms
was quite similar. However, only in the case of the glycoform
with the biantennary nonasaccharide the solubility properties of
the lipophilic glycoprotein were markedly improved.
6. Conclusions
The long-standing demand for homogeneous glycoproteins can
finally be met by chemical synthesis. Significant advances in
the synthesis of glycopeptides bearing full length N-glycans
were fruitfully combined with peptide ligation methods. This
has led to a rapidly increasing number of fully elaborated
N-glycoproteins of impressive size and diversity. The imple-
mentation of advanced ligation methods will simplify the
approaches further and allow taking on more complex targets
including the generation of libraries of glycoforms. With this
outlook the rapid transfer from basic glycobiology to industrial
applications is starting to become reality.
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